Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02526901

The Born in Guangzhou Cohort Study (BIGCS)

The Born in Guangzhou Cohort Study (BIGCS) was established to investigate the short- and long-term effects of exposure in early life on health consequences in Guangzhou, China. Data are collected regarding environmental, occupational and lifestyle exposures as well as health outcomes in later life. Biological samples including blood and tissue samples are also collected from the participants.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Over the past three decades, China is undergoing rapidly economic development. At the same time, the Western diet and urban lifestyle has been more common than before, which may lead to an increase of incidence of non-communicable chronic diseases, such as diabetes and malignancies. Notably, the current generation of Chinese adults, particularly those in their middle age or older, were born in an era where hardship and rationing was the norm and witnessed a social and epidemiological transition that might have a profound effect on their present health. In contrast, the younger generation is raised in relative material abundance, under the influence of traditional Chinese values such as a strong family orientation and an emphasis on academic success. A birth cohort with would provide an opportunity to examine the short- and long-term effects of exposure in early life on health consequences in this younger generation, in the context of rapid development in China.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women with <20 weeks of gestation
  • Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center
  • Permanent residents or families intended to remain in Guangzhou with their child for ≥3 years

Treatment and study plan

No intervention

Other

Primary outcomes

  1. Number of participant with pregnancy outcomes

    Time frame: At delivery

    Including abortion, stillbirth, live birth, preterm birth, low birth weight and birth defects

Secondary outcomes

  1. Neurodevelopment during early childhood

    Time frame: At age of 3 years

    Including adaptive, gross motor, fine motor, language, and social function; assessed using Gesell Developmental Schedules and Ages and Stages Questionnaire

  2. Weight changes during early childhood

    Time frame: At birth, age of 6 weeks, 6 months, 1 year and 3 years

    Weight changes from birth, 6 weeks, 6 months, 1 year to 3 years

  3. Height changes during early childhood

    Time frame: At birth, age of 6 weeks, 6 months, 1 year and 3 years

    Height changes from birth, 6 weeks, 6 months, 1 year to 3 years

  4. Changes of body composition during early childhood

    Time frame: At birth, age of 6 weeks, 6 months, 1 year and 3 years

    Changes of body composition from birth, 6 weeks, 6 months, 1 year to 3 years. Body composition is assessed using Dual Energy X-Ray Absorptiometry

Study contacts

Contact information is provided by the study sponsor or research team.

Jianrong He, MS

CONTACT

[email protected]

0086 20 38367159

Xiu Qiu, PhD

CONTACT

[email protected]

0086 20 38367160

Sponsors and collaborators

Lead sponsor

Guangzhou Women and Children's Medical Center

Other

Collaborators

  • University of Birmingham

Registry information

Acronym: BIGCS

Important dates

Study start
2012
Primary completion
2025
Study completion
2030
First posted
Aug 18, 2015
Registry last updated
Feb 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.